Pauling
ActiveAI-nativeNext-generation molecular simulation platform for drug discovery.
What it does
"Pauling is a cutting-edge health company revolutionizing drug discovery through its next-generation molecular simulation platform. Utilizing LLM agents, Pauling serves as a co-pilot for biology research, molecular simulation, and computational chemistry, streamlining the pre-clinical process from research literature review to lead optimization. By providing access to extensive bio and chem databases, target identification, hit discovery, molecular property prediction, and more, Pauling accelerates drug discovery, making it more efficient and cost-effective. With a focus on large-scale simulation setup, molecular dynamics, and lead optimization, Pauling aims to enhance the drug development process and facilitate seamless collaboration with contract research organizations for experimental validation."
Its site says now · captured 2026-08-23
Pauling.AI - From Idea to Drug Molecule in Days™
From idea to drug molecule in days™. Tell our agent your target and it will handle the rest. The first fully autonomous drug discovery platform.
Next to it in Healthcare and bio · AI-powered drug discovery platform
- AMPLY DiscoveryTechstars TS 2023
AMPLY Discovery — Turning the Dark Genome into Novel Medicines
- PolybiomicsPlug and Play PnP 2025
Polybiomics enables simultaneous measurements of multiple cellular features from the same sample in real-time.
- ConvexiaY Combinator S25
The world's first AI-maximalist pharma company
- Ditto BiosciencesY Combinator W26
Evolutionary intelligence for autoimmune disease
- Great Bay Bio 大湾生物Plug and Play PnP 2025
By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in drug development.
- Axiom TherapeuticsPlug and Play PnP 2025
AI-powered covalent drug discovery for untreatable cancers
- CytodymeTechstars TS 2025
Cytodyme
- WonderTxY Combinator S26
Extrapolative AI to unlock First-in-Class drugs